Skip to content

News

Discover the most recent news about our company

Prize-giving for young talents

Biosfer Teslab was awarded with one of the Premis Gresol for Young talents in front of 250 people at Flash Back room, Salou, from the Gresol Fundation. These prizes reclaim…

Biosfer Teslab to Boston

Biosfer to Boston, one of the 20 finalists projects of the international startups acceleration program, The Big Booster More information here.

Open call to join our operations team

Biosfer Teslab, an in vitro diagnostic company that develops novel NMR-based tests to improve cardiovascular risk assessment in patients at high cardio-metabolic risk, is looking for candidates to join our…

Open call for an Industrial Doctorate

Biosfer Teslab, an in vitro diagnostic company that develops novel NMR-based tests to improve cardiovascular risk assessment in patients at high cardio-metabolic risk, is looking for Industrial Doctorate candidates. The…

Call for an Industrial Doctoral Student

Biosfer Teslab is seeking candidates for an industrial doctorate to develop NMR-based in vitro diagnostic tests for cardiovascular risk assessment. Further information about the call can be found here.

ACCIÓ GRANT

BIOSFER TESLAB, SL with the support of ACTION in the frame of the Operative Program FEDER Catalonia 2014-2020 has carried out the “DEVELOPMENT And VALIDATION OF ADVANCED DIAGNOSTIC TEST Of INFLAMMATION And  INSULIN RESISTANCE FOR THE IMPROVEMENT OF  CARDIOVASCULAR RISK USING NUCLEAR MAGNETIC RESONANCE”  (RD15-1-0013).

Biosfer Teslab, along the project, has developed a system of prediction, using of advanced prediction tests, with the aim to improve the evaluation of cardiovascular risk and to identify those individuals with residual cardiovascular risk that would remain undiagnosed with classical risk factors.

In particular, the company has developed a glycoprotein test and a LMWM test - that includes, branched amino acids -, as they have been identified as inflammatory markers and involved in insulin resistance processes, respectively.

The Agency for the Competitiveness of the Company, ACTION, aiding to industrial research centers and experimental development, has granted Biosfer Teslab with an amount of 67,728.97 €.

This aid is programmed in the axis 1, "Boost research, technological development and innovation", specific objective OE 1.2.2, "Transfer and spreading of technology and cooperation between companies and universities or other research centers", line of action "Collaborative R+D projects" under the framework of the FEDER Operational Program of Catalonia 2014-2020